ANKRD62P1

Across TCGA pan-cancer cohorts, ANKRD62P1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of ANKRD62P1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where ANKRD62P1 RNA is repressed in tumor relative to normal tissue. In most cancer types ANKRD62P1 is over-expressed in tumor, although a few such as KIRC and KIRP show the opposite, repressed pattern.

KIRC, KIRP, and KICH are the cancer types where ANKRD62P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ANKRD62P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	III,IV	−0.174	<.001	12	view →
KIRP	Male	All	−0.115	.002	5	view →
KICH	All	All	−0.120	.016	2	view →
LUAD	Female	All	+0.049	.023	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

ANKRD62P1–KIRC

Open the KIRC breakdown →